ReferenceRRK5172

rEECur

International randomised controlled trial of chemotherapy for the treatment of recurrent and primary refractory Ewing sarcoma

Research Summary

Research Overview
Sponsor University of Birmingham
Project Status Open
Proposed End Date 01/09/2018
Study Run through CRF? No
Target number of patients agreed to recruit 20
Recruitment so far 7